The Holistic Value of Targeted Time-Limited Therapy in Chronic Lymphocytic Leukemia
Clinical Perspectives presented by:
Lindsey Roeker, MD
Assistant Attending Physician
Memorial Sloan Kettering
Cancer Center
Bita Fakhri, MD, MPH
Assistant Professor of Medicine (Hematology)
Stanford Health Care
Program Objectives
Learn CLL Disease State and Goals of Treatment
Explore Updates in CLL Treatment: 5-Year Off-Treatment Analyses of the CLL14 and MURANO Trials
Review CLL Patient Management Considerations
All content has been developed and authored
by AbbVie US Medical Affairs.
This site is intended for U.S. Healthcare Professionals only. Use of and access to this site are subject to the Terms of Use and Privacy Policy.
Copyright © 2024 AbbVie Inc. North Chicago, Illinois, U.S.A. BCL2-US-00073-MC, March 2024